Early Clinical Response after 2 Weeks of Sorafenib Therapy Predicts Outcomes and Anti-Tumor Response in Patients with Advanced Hepatocellular Carcinoma.

Early Clinical Response after 2 Weeks of Sorafenib Therapy Predicts Outcomes and Anti-Tumor Response in Patients with Advanced Hepatocellular Carcinoma.

We evaluated the relationship between the early clinical response after 2 weeks of sorafenib therapy and the outcomes and anti-tumor response in patients with advanced hepatocellular carcinoma.Fifty-seven patients who had intrahepatic hypervascular hepatocellular carcinoma and Child-Pugh (CP) class...

Full description

Bibliographic Details
Main Authors:	Teiji Kuzuya, Masatoshi Ishigami, Yoji Ishizu, Takashi Honda, Kazuhiko Hayashi, Yoshiaki Katano, Yoshiki Hirooka, Tetsuya Ishikawa, Isao Nakano, Hidemi Goto
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4589320?pdf=render

Similar Items

Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat Diet.
by: Norihiro Imai, et al.
Published: (2015-01-01)

Correction: Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat Diet.
by: Norihiro Imai, et al.
Published: (2016-01-01)

Effectiveness of a modified 6-Fr endoscopic nasobiliary drainage catheter for patients with preoperative perihilar cholangiocarcinoma
by: Hiroki Kawashima, et al.
Published: (2018-08-01)

Independent evolution of multi-dominant viral genome species observed in a hepatitis C virus carrier
by: Tomomi Ando, et al.
Published: (2022-12-01)

Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus.
by: Yoshihiko Tachi, et al.
Published: (2015-01-01)

Promoting notification and linkage of HBs antigen and anti-HCV antibody-positive patients through hospital alert system
by: Naoki Yoshioka, et al.
Published: (2017-05-01)

An Unusual Case of Pancreatic Metastasis from Squamous Cell Carcinoma of the Lung Diagnosed by EUS-Guided Fine Needle Biopsy
by: Takuya Ishikawa, et al.
Published: (2017-01-01)

Early Changes in Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin Are Useful Predictors of Antitumor Response to Durvalumab Plus Tremelimumab Therapy for Advanced Hepatocellular Carcinoma
by: Teiji Kuzuya, et al.
Published: (2024-07-01)

A Successful Living Donor Liver Transplantation Using Hepatic Iron Deposition Graft Suspected by Magnetic Resonance Imaging
by: Nobuhiko Kurata, et al.
Published: (2023-01-01)

Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response
by: Teiji Kuzuya, et al.
Published: (2024-10-01)

Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma
by: Song-Fong Huang, et al.
Published: (2022-09-01)

Images of colonic real-time tissue sonoelastography correlate with those of colonoscopy and may predict response to therapy in patients with ulcerative colitis
by: Miyahara Ryoji, et al.
Published: (2011-03-01)

Real-World Effectiveness and Risk Factors for Discontinuation of Ustekinumab in Ulcerative Colitis
by: Genta Uchida, et al.
Published: (2023-06-01)

The Role of Endoscopic Ultrasound in the Diagnosis of Gallbladder Lesions
by: Senju Hashimoto, et al.
Published: (2021-09-01)

Endoscopic ultrasound in the diagnosis of acinar cell carcinoma of the pancreas: contrast-enhanced endoscopic ultrasound, endoscopic ultrasound elastography, and pathological correlation
by: Tanyaporn Chantarojanasiri, et al.
Published: (2016-11-01)

Diagnosis of vascular invasion in pancreatic ductal adenocarcinoma using endoscopic ultrasound elastography
by: Kenta Yamada, et al.
Published: (2020-03-01)

Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma
by: Bo Hyun Kim, et al.
Published: (2019-05-01)

Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
by: Simone Famularo, MD, et al.
Published: (2023-03-01)

Combinational use of lipid-based reagents for efficient transfection of primary fibroblasts and hepatoblasts
by: Kazuhiro Ishiguro, et al.
Published: (2017-07-01)

Complete Response after Short-Term Sorafenib Treatment in a Patient with Lymph Node Metastasis of Hepatocellular Carcinoma
by: Hajime Mizukami, et al.
Published: (2012-07-01)

Comparison of the diagnostic ability of blue laser imaging magnification versus pit pattern analysis for colorectal polyps
by: Arihiro Nakano, et al.
Published: (2017-03-01)

Complete Response to Sorafenib Rechallenge in a Patient with Metastatic Renal Cell Carcinoma
by: Ryo Kasahara, et al.
Published: (2017-01-01)

Tumor microenvironment responsive nano-platform for overcoming sorafenib resistance of hepatocellular carcinoma
by: Wenjing Xu, et al.
Published: (2024-02-01)

Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection
by: Liming Zheng, et al.
Published: (2021-11-01)

Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma
by: Kuo-Wei Huang, et al.
Published: (2022-05-01)

Complete response for advanced liver cancer during sorafenib therapy: Case Report
by: Romano Antonio, et al.
Published: (2011-01-01)

A rare case of inflammatory polyp in the common bile duct with cholangitis
by: Kazunori Nakaoka, et al.
Published: (2023-04-01)

Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats
by: Agnieszka Karbownik, et al.
Published: (2020-06-01)

PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma
by: Pusen Wang, et al.
Published: (2020-10-01)

Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma
by: Satoshi Narahara, et al.
Published: (2022-05-01)

Erratum to “Durable Objective Response to Sorafenib and Role of Sequential Treatment in Unresectable Hepatocellular Carcinoma”
Published: (2022-07-01)

Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification
by: Raphael Brandão Moreira, et al.
Published: (2015-02-01)

Complete response of advanced hepatocellular carcinoma to sorafenib: another case and a comprehensive review
by: Tae Suk Kim, et al.
Published: (2017-12-01)

Primary sclerosing cholangitis with partial steroid responsiveness: a case report
by: Satoshi Yamamoto, et al.
Published: (2023-05-01)

Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma
by: Kazunori Nakaoka, et al.
Published: (2023-01-01)

The Development of Lipid-Based Sorafenib Granules to Enhance the Oral Absorption of Sorafenib
by: Jaylen C. Mans, et al.
Published: (2023-11-01)

Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma
by: Ryu Sasaki, MD, PhD, et al.
Published: (2022-05-01)

Distinct features of two lipid droplets types in cell nuclei from patients with liver diseases
by: Norihiro Imai, et al.
Published: (2023-04-01)

Novel Insights Into the Immune-Regulatory Functions of Mast Cells in the Cutaneous Immune Response
by: Tetsuya Honda, et al.
Published: (2022-05-01)

ATRA sensitized the response of hepatocellular carcinoma to Sorafenib by downregulation of p21-activated kinase 1
by: Kai Wang, et al.
Published: (2023-08-01)